Status:

RECRUITING

A Research Study to See How Insulin Icodec Helps People With Type 1 Diabetes Control Their Blood Sugar

Lead Sponsor:

Novo Nordisk A/S

Conditions:

Diabetes Mellitus, Type 1

Eligibility:

All Genders

18+ years

Brief Summary

The study will look at how well insulin icodec controls blood sugar levels in participants who have never used it before. Participants with type 1 diabetes (T1D) will be treated with insulin icodec as...

Eligibility Criteria

Inclusion

  • Signed consent obtained before any study-related activities (study-related activities are any procedures related to recording of data according to the protocol).
  • The decision to initiate treatment with commercially available insulin icodec has been made by the participant/legally acceptable representative (LAR) and the treating physician before and independently from the decision to include the participant in this study.
  • Male or female, age greater than or equal to (≥) 18 years at the time of signing informed consent.
  • Diagnosed with T1D ≥ 1 year before signing informed consent.
  • Treated with multiple daily insulin injections (daily basal insulin analogue and bolus insulin analogue regimen) ≥ 6 months before signing informed consent.
  • Available HbA1c value less than or equal to (≤) 90 days prior to the 'Initiation visit' (V1) or HbA1c measurement taken in relation with the 'Initiation visit' (V1) if in line with local clinical practice.
  • Treatment naïve to once-weekly insulin prior to the 'Initiation Visit' (V1).

Exclusion

  • Previous participation in this study. Participation is defined as having given informed consent in this study.
  • Treatment with any investigational drug within 30 days prior to enrolment into the study.
  • Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation.

Key Trial Info

Start Date :

August 28 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

January 20 2027

Estimated Enrollment :

245 Patients enrolled

Trial Details

Trial ID

NCT07160816

Start Date

August 28 2025

End Date

January 20 2027

Last Update

January 9 2026

Active Locations (35)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 9 (35 locations)

1

Hausärztliche und Diabetologische Praxis Pirna

Pirna, LÄK Sachsen, Germany, 01796

2

Zuckerpraxis Dr. Ewald Jammers

Bramsche, Germany, 49565

3

Studiengesellschaft Dres. Könemann/Steinmann GbR

Bünde, Germany, 32257

4

Diabeteszentrum-Do Dres. K U. Ch. Busch GbR

Dortmund, Germany, 44137